Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study on the Management of COMISA
NCT07743931Recruiting
- Sponsor
- CHU Grenoble Alpes
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial of daridorexant in Comorbid Insomnia and Sleep Apnea (COMISA), sponsored by CHU Grenoble Alpes. Primary endpoint: Continuous Positive Airway Pressure Adherence at 4 months. Started Sep 2026; status: recruiting.
02
Drugs
daridorexant
03
Conditions
Comorbid Insomnia and Sleep Apnea (COMISA)
Beyond the preview
Go deeper on NCT07743931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743931.